← Leaderboards
Guogen Shan
University Of Nevada Las Vegas
$1,806,960
Attributed
$1,806,960
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $402.5K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,806,960 · 3
By mechanism
R01$1,490,374 · 1
R03$316,586 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposDrug DevelopmentParticipantClinical TrialsS DiseaseSuccessTau ProteinsPerformanceResearch DesignPharmaceutical PreparationsImpaired CognitionSample SizeBiological MarkersS Disease PatientEnrollmentAffectFollow-UpCharacteristicsDesignFlexibilityNeuroimagingDementiaRisk FactorsVisit
Grant awards (10)
Alzheimer's Disease: New Trial Designs for Emerging Challenges$282,789
R01 · FY2025 · AG · contact PI
Alzheimer's Disease: New Trial Designs for Emerging Challenges$289,505
R01 · FY2024 · AG · contact PI
Application of deep learning and novel survival models to predict MCI-to-AD dementia progression$77,952
R03 · FY2024 · AG · contact PI
Alzheimer's Disease: New Trial Designs for Emerging Challenges$290,405
R01 · FY2023 · AG · contact PI
Application of deep learning and novel survival models to predict MCI-to-AD dementia progression$86,134
R03 · FY2023 · AG · contact PI
Alzheimer's Disease: New Trial Designs for Emerging Challenges$301,393
R01 · FY2022 · AG · contact PI
Adaptive randomized designs for cancer clinical trials by using integer algorithms and exact Monte Carlo methods$76,250
R03 · FY2022 · CA · contact PI
Alzheimer's Disease: New Trial Designs for Emerging Challenges$319,215
R01 · FY2021 · AG · contact PI
Adaptive randomized designs for cancer clinical trials by using integer algorithms and exact Monte Carlo methods$76,250
R03 · FY2021 · CA · contact PI
Alzheimer's Disease: New Trial Designs for Emerging Challenges$7,067
R01 · FY2021 · AG · contact PI